http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201026316-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8857ad5979cbaf34d6a688468830ea8 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 |
| filingDate | 2009-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd35f3903b747d5509df212f11325a05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e3d56819c51ae033f1e0f9eb29699fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f028d6970260bc1ef0fbad4c62cea26a |
| publicationDate | 2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201026316-A |
| titleOfInvention | Novel anti-tumor protein |
| abstract | This invention provides an anti-tumor protein, which is characterized by (a) having an N-terminal amino acid sequence of ASTVIP, wherein A represents alanine residue, S represents serine residue, T represents threonine residue, V represents valine residue, I represents isoleucine residue, P represents proline residue, (b) having a LC/MSMS spectrum as shown in figure 7(A), and (c) having a molecular weight of 30 kDa. This invention also provides a pharmaceutical composition comprising the anti-tumor protein and the use and application of the anti-tumor protein. |
| priorityDate | 2009-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.